Case Study: Advancing Patient Access Through Early Engagement with Payers & the Cell & Gene Therapy Access Model

• Engaging payers early to educate on the product and disease state while generating appropriate outcomes to support contracting
• Building evidence of value to drive coverage while addressing reimbursement challenges for qualified treatment centres
• Showcasing substantial growth in patient adoption over two years, and outlining challenges that remain

Speakers:

Ravi Singh

Vice President - Market Access, Advocacy & Policy

Genetix Biotherapeutics